Assessment of Inspiratory Muscles Strength and Endurance Evolution on Difficult to Wean Patients in Intensive Care Unit
NCT ID: NCT03140267
Last Updated: 2020-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2017-05-14
2020-01-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To perform the best IMT program, we need to know the physio-pathology of the diaphragm in difficult to wean patients.
This study proposes to discriminate the two main characteristics of the inspiratory muscles: strength and endurance.
By analyzing the evolution of strength and endurance during all the weaning period, we want to know which characteristic has the more deficiency to adapt in a second time an effective program of IMT.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Can High Intensity Inspiratory Muscle Training Improve Inspiratory Muscle Strength and Accelerate Weaning in Medical Patients With Difficulty on Weaning?
NCT04347317
Comparison of the Impact of Three Programs of Inspiratory Muscles.
NCT02855619
Effects of IMT on Weaning and Diaphragmatic Function in PMV Patients
NCT07200037
Identifying the Optimal IMT Dose in ICU
NCT07256821
Muscle Recruitment During Neck Flexion and Inspiratory Muscle Training
NCT05710432
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We are going to conduct an interventional trial because of Peak Pressure measure, which is not measure in care practice. Following 18h of invasive mechanical ventilation in a controlled mode, the failure of the first single breathe trial of 2 hours and the presence of sevrability criterias defined by the European consensus conference in 2007, 80 participants will be included in the medical intensive care unit of Bordeaux's hospital. We'll perform measurements of the Maximal Inspiratory Pressure and Peak Pressure from the inclusion to the extubation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Difficult to wean patients
Maximal Inspiratory Pressure and Peak Pressure from the inclusion day to the extubation day will be measure.
Difficult to wean patients
Subjects will be following during 18 hours in an invasive mechanical ventilation in a controlled mode. After failure of first single breath trial during 2 hours and presence of sevrability criterias defined by the European consensus conference in 2007, Maximal Inspiratory Pressure and Peak Pressure will be measure.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Difficult to wean patients
Subjects will be following during 18 hours in an invasive mechanical ventilation in a controlled mode. After failure of first single breath trial during 2 hours and presence of sevrability criterias defined by the European consensus conference in 2007, Maximal Inspiratory Pressure and Peak Pressure will be measure.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* First single breathe trial of 2 hours failure;
* Presence of sevrability criterias definied by the European consensus conference in 2007 as usually used:
* diminution of the sedfative agents ;
* Patients with spontaneous beath in VAC mode or patient ventilated in a VSAI-PEP mode;
* PaO2/FiO2 ≥150;
* Absence d'inotropes ou de vasopresseurs à forte dose ou dose croissante (\<1mg/h);
* SaO2 \> 90% with FiO2 ≤ 50%;
* PEP ≤ 8cmH2O;
* Corporal température between 36°C and 39°C;
* Glasgow Score ≥ 8;
* Patient or family consent.
Exclusion Criteria
* medically unstable;
* Poor vital pronostic at very short term;
* Cardiac arrest with a poor neurological prognostic;
* Neuromuscular disease ;
* Tracheostomy ;
* Current pregnancy ;
* Patients with guardianship or trusteeship.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Perez Paul, Dr
Role: STUDY_CHAIR
USMR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Haut-Lévêque
Bordeaux, , France
Hôpital Pellegrin
Bordeaux, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUBX 2015/37
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.